Medicine and Dentistry
Uterine Cancer
100%
Endometrium Carcinoma
47%
Cervical Cancer
46%
Neoplasm
45%
Retroperitoneal Lymph Node Dissection
30%
Recurrent Disease
28%
Ovarian Cancer
26%
Radical Hysterectomy
19%
Biological Marker
19%
Diseases
17%
Metastatic Carcinoma
16%
Sentinel Lymph Node
15%
Lymph Node
15%
Surgery
13%
Pelvis
12%
Laparoscopic Surgery
12%
Malignant Neoplasm
12%
Cancer
12%
Postoperative Complication
10%
Overall Survival
10%
Technetium-99
10%
Aspiration
9%
Proteomics
9%
Upregulation
9%
Carcinoma
8%
Bleeding
8%
microRNA
8%
Sentinel Node
8%
Transcription Factors
7%
Indocyanine Green
7%
Mesenchymal-Epithelial Transition
7%
Pelvis Lymphadenectomy
6%
Endometrium
6%
Disease Free Survival
6%
Signal Transduction
6%
Tumor Invasion
6%
Systematic Review
6%
Cytoreductive Surgery
6%
Cancer Cell
6%
Minimally Invasive Procedure
6%
Operation Duration
6%
Liquid Biopsy
6%
Carcinogenesis
5%
Radiation Therapy
5%
Biopsy Technique
5%
Stress Incontinence
5%
Meta-Analysis
5%
Prognostic Factor
5%
Cell Adhesion Proteins
5%
Body Mass Index
5%
Keyphrases
Endometrial Cancer
90%
Endometrial Carcinoma
35%
Tumor
25%
Extraperitoneal
20%
Early-stage Cervical Cancer
18%
Locally Advanced Cervical Cancer
18%
Para-aortic Lymphadenectomy
18%
Sentinel Lymph Node Mapping
15%
Ovarian Cancer
15%
ETV5
15%
Uterine Aspirate
15%
Radical Hysterectomy
12%
MicroRNA
11%
Cervical Cancer
11%
Myometrial Infiltration
10%
Sentinel Lymph Node
10%
Prognostic Biomarker
10%
Surgical Staging
10%
Cancer Patients
10%
Overall Survival
10%
Oncological Outcomes
9%
Metastasis
9%
Technetium-99m
9%
Clinical Management
8%
Surgical Treatment
8%
Extracellular Vesicles
8%
Endometrioid Endometrial Carcinoma
8%
Advanced Ovarian Cancer
8%
Pelvic Lymphadenectomy
8%
Molecular Profile
7%
Indocyanine Green
7%
Epithelial-to-mesenchymal Transition
7%
Gynecologic Malignancies
7%
L1 Cell Adhesion Molecule (L1CAM)
7%
Transcription Factor
7%
Aortic Lymphadenectomy
7%
Endometrioid Endometrial Cancer
7%
Endometrioid
7%
Lymph Node Metastasis
7%
Disease-free Survival
7%
Invasive Cervical Cancer
7%
Laparoscopy
6%
Carcinoma
6%
Runt-related Transcription Factor 1 (RUNX1)
6%
Spain
6%
Sentinel Lymph Node Biopsy
6%
Early Endometrial Cancer
6%
Advanced Stage
6%
Liquid Biopsy
6%
Clinical Outcomes
6%